Critical role of lectin pathway mediated by MBL-associated serine proteases in complement activation for the pathogenesis in systemic lupus erythematosus Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.heliyon.2023.e19072
In complement activation system, although the classical pathway has shown to play a critical role for the pathogenesis of SLE, the role of lectin pathway has remained unknown in the pathogenesis of SLE. As Mannose-binding lectin-associated serine proteases (MASPs) are associated with activation of the lectin pathway, we conducted this study to clarify MASPs associations in the pathogenesis of SLE. We evaluated the serum level of MASPs (MASP-1 and MASP-2) in total 68 SLE patients consisting of 15 patients with biopsy-confirmed membranous lupus nephritis (M-LN), 35 patients with biopsy-confirmed proliferative lupus nephritis (P-LN), and 18 SLE patients without LN (non-LN). Our data showed that the serum levels of MASPs were reduced in both P-LN and non-LN although those of M-LN were not reduced. Our data show that the lectin pathway mediated by MASPs plays a critical role for the pathogenesis of SLE except for M-LN.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.heliyon.2023.e19072
- http://www.cell.com/article/S2405844023062801/pdf
- OA Status
- gold
- Cited By
- 6
- References
- 17
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4385721057
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4385721057Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.heliyon.2023.e19072Digital Object Identifier
- Title
-
Critical role of lectin pathway mediated by MBL-associated serine proteases in complement activation for the pathogenesis in systemic lupus erythematosusWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-08-01Full publication date if available
- Authors
-
Yuko Asanuma, Kazuhisa NOZAWA, Masakazu Matsushita, Makio Kusaoi, Yoshiyuki Abe, Ken Yamaji, Naoto TamuraList of authors in order
- Landing page
-
https://doi.org/10.1016/j.heliyon.2023.e19072Publisher landing page
- PDF URL
-
https://www.cell.com/article/S2405844023062801/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.cell.com/article/S2405844023062801/pdfDirect OA link when available
- Concepts
-
Lectin pathway, Pathogenesis, Mannan-binding lectin, Complement system, Proteases, Lupus nephritis, Immunology, Lectin, Alternative complement pathway, Medicine, Biology, Pathology, Biochemistry, Immune system, Enzyme, DiseaseTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 4Per-year citation counts (last 5 years)
- References (count)
-
17Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4385721057 |
|---|---|
| doi | https://doi.org/10.1016/j.heliyon.2023.e19072 |
| ids.doi | https://doi.org/10.1016/j.heliyon.2023.e19072 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37636359 |
| ids.openalex | https://openalex.org/W4385721057 |
| fwci | 1.16362121 |
| type | article |
| title | Critical role of lectin pathway mediated by MBL-associated serine proteases in complement activation for the pathogenesis in systemic lupus erythematosus |
| biblio.issue | 8 |
| biblio.volume | 9 |
| biblio.last_page | e19072 |
| biblio.first_page | e19072 |
| topics[0].id | https://openalex.org/T10993 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Complement system in diseases |
| topics[1].id | https://openalex.org/T11029 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9998000264167786 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2727 |
| topics[1].subfield.display_name | Nephrology |
| topics[1].display_name | Renal Diseases and Glomerulopathies |
| topics[2].id | https://openalex.org/T10308 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9997000098228455 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2745 |
| topics[2].subfield.display_name | Rheumatology |
| topics[2].display_name | Systemic Lupus Erythematosus Research |
| is_xpac | False |
| apc_list.value | 1750 |
| apc_list.currency | USD |
| apc_list.value_usd | 1750 |
| apc_paid.value | 1750 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1750 |
| concepts[0].id | https://openalex.org/C203880312 |
| concepts[0].level | 5 |
| concepts[0].score | 0.9062986373901367 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q14864145 |
| concepts[0].display_name | Lectin pathway |
| concepts[1].id | https://openalex.org/C2780942790 |
| concepts[1].level | 2 |
| concepts[1].score | 0.8480896949768066 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q372016 |
| concepts[1].display_name | Pathogenesis |
| concepts[2].id | https://openalex.org/C189413060 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7513231039047241 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q415443 |
| concepts[2].display_name | Mannan-binding lectin |
| concepts[3].id | https://openalex.org/C111684460 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6854456663131714 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q334848 |
| concepts[3].display_name | Complement system |
| concepts[4].id | https://openalex.org/C182220744 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6239776015281677 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7251226 |
| concepts[4].display_name | Proteases |
| concepts[5].id | https://openalex.org/C2779912601 |
| concepts[5].level | 3 |
| concepts[5].score | 0.6070436239242554 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1621830 |
| concepts[5].display_name | Lupus nephritis |
| concepts[6].id | https://openalex.org/C203014093 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5642396211624146 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[6].display_name | Immunology |
| concepts[7].id | https://openalex.org/C2780758401 |
| concepts[7].level | 2 |
| concepts[7].score | 0.5161867737770081 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q408693 |
| concepts[7].display_name | Lectin |
| concepts[8].id | https://openalex.org/C189446657 |
| concepts[8].level | 4 |
| concepts[8].score | 0.41362589597702026 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q4736500 |
| concepts[8].display_name | Alternative complement pathway |
| concepts[9].id | https://openalex.org/C71924100 |
| concepts[9].level | 0 |
| concepts[9].score | 0.34424299001693726 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[9].display_name | Medicine |
| concepts[10].id | https://openalex.org/C86803240 |
| concepts[10].level | 0 |
| concepts[10].score | 0.30579957365989685 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[10].display_name | Biology |
| concepts[11].id | https://openalex.org/C142724271 |
| concepts[11].level | 1 |
| concepts[11].score | 0.20425012707710266 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[11].display_name | Pathology |
| concepts[12].id | https://openalex.org/C55493867 |
| concepts[12].level | 1 |
| concepts[12].score | 0.1088823676109314 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[12].display_name | Biochemistry |
| concepts[13].id | https://openalex.org/C8891405 |
| concepts[13].level | 2 |
| concepts[13].score | 0.09637284278869629 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[13].display_name | Immune system |
| concepts[14].id | https://openalex.org/C181199279 |
| concepts[14].level | 2 |
| concepts[14].score | 0.06044849753379822 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q8047 |
| concepts[14].display_name | Enzyme |
| concepts[15].id | https://openalex.org/C2779134260 |
| concepts[15].level | 2 |
| concepts[15].score | 0.043943166732788086 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[15].display_name | Disease |
| keywords[0].id | https://openalex.org/keywords/lectin-pathway |
| keywords[0].score | 0.9062986373901367 |
| keywords[0].display_name | Lectin pathway |
| keywords[1].id | https://openalex.org/keywords/pathogenesis |
| keywords[1].score | 0.8480896949768066 |
| keywords[1].display_name | Pathogenesis |
| keywords[2].id | https://openalex.org/keywords/mannan-binding-lectin |
| keywords[2].score | 0.7513231039047241 |
| keywords[2].display_name | Mannan-binding lectin |
| keywords[3].id | https://openalex.org/keywords/complement-system |
| keywords[3].score | 0.6854456663131714 |
| keywords[3].display_name | Complement system |
| keywords[4].id | https://openalex.org/keywords/proteases |
| keywords[4].score | 0.6239776015281677 |
| keywords[4].display_name | Proteases |
| keywords[5].id | https://openalex.org/keywords/lupus-nephritis |
| keywords[5].score | 0.6070436239242554 |
| keywords[5].display_name | Lupus nephritis |
| keywords[6].id | https://openalex.org/keywords/immunology |
| keywords[6].score | 0.5642396211624146 |
| keywords[6].display_name | Immunology |
| keywords[7].id | https://openalex.org/keywords/lectin |
| keywords[7].score | 0.5161867737770081 |
| keywords[7].display_name | Lectin |
| keywords[8].id | https://openalex.org/keywords/alternative-complement-pathway |
| keywords[8].score | 0.41362589597702026 |
| keywords[8].display_name | Alternative complement pathway |
| keywords[9].id | https://openalex.org/keywords/medicine |
| keywords[9].score | 0.34424299001693726 |
| keywords[9].display_name | Medicine |
| keywords[10].id | https://openalex.org/keywords/biology |
| keywords[10].score | 0.30579957365989685 |
| keywords[10].display_name | Biology |
| keywords[11].id | https://openalex.org/keywords/pathology |
| keywords[11].score | 0.20425012707710266 |
| keywords[11].display_name | Pathology |
| keywords[12].id | https://openalex.org/keywords/biochemistry |
| keywords[12].score | 0.1088823676109314 |
| keywords[12].display_name | Biochemistry |
| keywords[13].id | https://openalex.org/keywords/immune-system |
| keywords[13].score | 0.09637284278869629 |
| keywords[13].display_name | Immune system |
| keywords[14].id | https://openalex.org/keywords/enzyme |
| keywords[14].score | 0.06044849753379822 |
| keywords[14].display_name | Enzyme |
| keywords[15].id | https://openalex.org/keywords/disease |
| keywords[15].score | 0.043943166732788086 |
| keywords[15].display_name | Disease |
| language | en |
| locations[0].id | doi:10.1016/j.heliyon.2023.e19072 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2898612692 |
| locations[0].source.issn | 2405-8440 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2405-8440 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Heliyon |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_lineage_names | Elsevier BV |
| locations[0].license | cc-by |
| locations[0].pdf_url | http://www.cell.com/article/S2405844023062801/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Heliyon |
| locations[0].landing_page_url | https://doi.org/10.1016/j.heliyon.2023.e19072 |
| locations[1].id | pmid:37636359 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Heliyon |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37636359 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10457435 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10457435/pdf/main.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Heliyon |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10457435 |
| locations[3].id | pmh:oai:doaj.org/article:1e52d0f7c8e647f28030795c84393849 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Heliyon, Vol 9, Iss 8, Pp e19072- (2023) |
| locations[3].landing_page_url | https://doaj.org/article/1e52d0f7c8e647f28030795c84393849 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5075022961 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5703-9032 |
| authorships[0].author.display_name | Yuko Asanuma |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I34077901 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[0].institutions[0].id | https://openalex.org/I34077901 |
| authorships[0].institutions[0].ror | https://ror.org/01692sz90 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I34077901 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Juntendo University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Yuko Asanuma |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[1].author.id | https://openalex.org/A5059769749 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8812-956X |
| authorships[1].author.display_name | Kazuhisa NOZAWA |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I34077901, https://openalex.org/I4210141235 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Internal Medicine and Rheumatology, Juntendo University Koshigaya Hospital, Saitama, Japan |
| authorships[1].institutions[0].id | https://openalex.org/I4210141235 |
| authorships[1].institutions[0].ror | https://ror.org/03fyvh407 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210141235 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Dokkyo Medical University Saitama Medical Center |
| authorships[1].institutions[1].id | https://openalex.org/I34077901 |
| authorships[1].institutions[1].ror | https://ror.org/01692sz90 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I34077901 |
| authorships[1].institutions[1].country_code | JP |
| authorships[1].institutions[1].display_name | Juntendo University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Kazuhisa Nozawa |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Department of Internal Medicine and Rheumatology, Juntendo University Koshigaya Hospital, Saitama, Japan |
| authorships[2].author.id | https://openalex.org/A5014930296 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3058-5778 |
| authorships[2].author.display_name | Masakazu Matsushita |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I34077901 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[2].institutions[0].id | https://openalex.org/I34077901 |
| authorships[2].institutions[0].ror | https://ror.org/01692sz90 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I34077901 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Juntendo University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Masakazu Matsushita |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[3].author.id | https://openalex.org/A5037755032 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0064-4765 |
| authorships[3].author.display_name | Makio Kusaoi |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I34077901 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[3].institutions[0].id | https://openalex.org/I34077901 |
| authorships[3].institutions[0].ror | https://ror.org/01692sz90 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I34077901 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | Juntendo University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Makio Kusaoi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[4].author.id | https://openalex.org/A5101528580 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-1014-2868 |
| authorships[4].author.display_name | Yoshiyuki Abe |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I34077901 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[4].institutions[0].id | https://openalex.org/I34077901 |
| authorships[4].institutions[0].ror | https://ror.org/01692sz90 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I34077901 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Juntendo University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Yoshiyuki Abe |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[5].author.id | https://openalex.org/A5111024762 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0565-1828 |
| authorships[5].author.display_name | Ken Yamaji |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I34077901 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[5].institutions[0].id | https://openalex.org/I34077901 |
| authorships[5].institutions[0].ror | https://ror.org/01692sz90 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I34077901 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | Juntendo University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Ken Yamaji |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[6].author.id | https://openalex.org/A5064110644 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-1729-2954 |
| authorships[6].author.display_name | Naoto Tamura |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I34077901 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| authorships[6].institutions[0].id | https://openalex.org/I34077901 |
| authorships[6].institutions[0].ror | https://ror.org/01692sz90 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I34077901 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | Juntendo University |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Naoto Tamura |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.cell.com/article/S2405844023062801/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Critical role of lectin pathway mediated by MBL-associated serine proteases in complement activation for the pathogenesis in systemic lupus erythematosus |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10993 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Complement system in diseases |
| related_works | https://openalex.org/W1576564327, https://openalex.org/W2041992276, https://openalex.org/W1707432425, https://openalex.org/W2414144754, https://openalex.org/W2392234125, https://openalex.org/W2125436241, https://openalex.org/W2071378151, https://openalex.org/W1970734671, https://openalex.org/W4385721057, https://openalex.org/W1997754935 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1016/j.heliyon.2023.e19072 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2898612692 |
| best_oa_location.source.issn | 2405-8440 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2405-8440 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Heliyon |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_lineage_names | Elsevier BV |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | http://www.cell.com/article/S2405844023062801/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Heliyon |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.heliyon.2023.e19072 |
| primary_location.id | doi:10.1016/j.heliyon.2023.e19072 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2898612692 |
| primary_location.source.issn | 2405-8440 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2405-8440 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Heliyon |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_lineage_names | Elsevier BV |
| primary_location.license | cc-by |
| primary_location.pdf_url | http://www.cell.com/article/S2405844023062801/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Heliyon |
| primary_location.landing_page_url | https://doi.org/10.1016/j.heliyon.2023.e19072 |
| publication_date | 2023-08-01 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2117644242, https://openalex.org/W2098109767, https://openalex.org/W2972127807, https://openalex.org/W3042589753, https://openalex.org/W2890371891, https://openalex.org/W4200444174, https://openalex.org/W2803746906, https://openalex.org/W1970734671, https://openalex.org/W3042971072, https://openalex.org/W2121960517, https://openalex.org/W4221124919, https://openalex.org/W2046346283, https://openalex.org/W3126344636, https://openalex.org/W2111940985, https://openalex.org/W3033038900, https://openalex.org/W2166822765, https://openalex.org/W2591717879 |
| referenced_works_count | 17 |
| abstract_inverted_index.a | 12, 134 |
| abstract_inverted_index.15 | 77 |
| abstract_inverted_index.18 | 94 |
| abstract_inverted_index.35 | 85 |
| abstract_inverted_index.68 | 72 |
| abstract_inverted_index.As | 33 |
| abstract_inverted_index.In | 0 |
| abstract_inverted_index.LN | 98 |
| abstract_inverted_index.We | 60 |
| abstract_inverted_index.by | 131 |
| abstract_inverted_index.in | 28, 55, 70, 111 |
| abstract_inverted_index.of | 18, 22, 31, 43, 58, 65, 76, 107, 118, 140 |
| abstract_inverted_index.to | 10, 51 |
| abstract_inverted_index.we | 47 |
| abstract_inverted_index.Our | 100, 123 |
| abstract_inverted_index.SLE | 73, 95, 141 |
| abstract_inverted_index.and | 68, 93, 114 |
| abstract_inverted_index.are | 39 |
| abstract_inverted_index.for | 15, 137, 143 |
| abstract_inverted_index.has | 8, 25 |
| abstract_inverted_index.not | 121 |
| abstract_inverted_index.the | 5, 16, 20, 29, 44, 56, 62, 104, 127, 138 |
| abstract_inverted_index.M-LN | 119 |
| abstract_inverted_index.P-LN | 113 |
| abstract_inverted_index.SLE, | 19 |
| abstract_inverted_index.SLE. | 32, 59 |
| abstract_inverted_index.both | 112 |
| abstract_inverted_index.data | 101, 124 |
| abstract_inverted_index.play | 11 |
| abstract_inverted_index.role | 14, 21, 136 |
| abstract_inverted_index.show | 125 |
| abstract_inverted_index.that | 103, 126 |
| abstract_inverted_index.this | 49 |
| abstract_inverted_index.were | 109, 120 |
| abstract_inverted_index.with | 41, 79, 87 |
| abstract_inverted_index.M-LN. | 144 |
| abstract_inverted_index.MASPs | 53, 66, 108, 132 |
| abstract_inverted_index.level | 64 |
| abstract_inverted_index.lupus | 82, 90 |
| abstract_inverted_index.plays | 133 |
| abstract_inverted_index.serum | 63, 105 |
| abstract_inverted_index.shown | 9 |
| abstract_inverted_index.study | 50 |
| abstract_inverted_index.those | 117 |
| abstract_inverted_index.total | 71 |
| abstract_inverted_index.except | 142 |
| abstract_inverted_index.lectin | 23, 45, 128 |
| abstract_inverted_index.levels | 106 |
| abstract_inverted_index.non-LN | 115 |
| abstract_inverted_index.serine | 36 |
| abstract_inverted_index.showed | 102 |
| abstract_inverted_index.(M-LN), | 84 |
| abstract_inverted_index.(MASP-1 | 67 |
| abstract_inverted_index.(MASPs) | 38 |
| abstract_inverted_index.(P-LN), | 92 |
| abstract_inverted_index.MASP-2) | 69 |
| abstract_inverted_index.clarify | 52 |
| abstract_inverted_index.pathway | 7, 24, 129 |
| abstract_inverted_index.reduced | 110 |
| abstract_inverted_index.system, | 3 |
| abstract_inverted_index.unknown | 27 |
| abstract_inverted_index.without | 97 |
| abstract_inverted_index.although | 4, 116 |
| abstract_inverted_index.critical | 13, 135 |
| abstract_inverted_index.mediated | 130 |
| abstract_inverted_index.pathway, | 46 |
| abstract_inverted_index.patients | 74, 78, 86, 96 |
| abstract_inverted_index.reduced. | 122 |
| abstract_inverted_index.remained | 26 |
| abstract_inverted_index.(non-LN). | 99 |
| abstract_inverted_index.classical | 6 |
| abstract_inverted_index.conducted | 48 |
| abstract_inverted_index.evaluated | 61 |
| abstract_inverted_index.nephritis | 83, 91 |
| abstract_inverted_index.proteases | 37 |
| abstract_inverted_index.activation | 2, 42 |
| abstract_inverted_index.associated | 40 |
| abstract_inverted_index.complement | 1 |
| abstract_inverted_index.consisting | 75 |
| abstract_inverted_index.membranous | 81 |
| abstract_inverted_index.associations | 54 |
| abstract_inverted_index.pathogenesis | 17, 30, 57, 139 |
| abstract_inverted_index.proliferative | 89 |
| abstract_inverted_index.Mannose-binding | 34 |
| abstract_inverted_index.biopsy-confirmed | 80, 88 |
| abstract_inverted_index.lectin-associated | 35 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 95 |
| corresponding_author_ids | https://openalex.org/A5059769749 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I34077901, https://openalex.org/I4210141235 |
| citation_normalized_percentile.value | 0.8006272 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |